NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/16/2023
Back to search
Official data from USPTO
FAX PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
66
Latest update
07/08/2023
Trademark type
Combined
Nice classes
44
Filing date
01/28/2020
Registration date
05/16/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/16/2023
Last transaction
07/08/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
05/13/2019
First use in commerce
01/01/2022
Drawing code
3
Owner type
03
Owner location
Miami, FL
Examiner
JACKSON, STEVEN
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "FAX" which has two colors; the "FA" is in blue, and the "X" is in red with blue lines inside the "X" to make it appear as if the "X" is a DNA strand. The stylized wording "pharma" appears below the stylized wording "FAX" in gray lettering.
Holders and representatives
Holders
Fax Pharma Inc.
Representatives
Erik Lichter THE LICHTER LAW GROUP
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Cosmetic skin care services; Medical services for the treatment of skin cancer; Medical skin care services
Publications
History of USPTO decisions and trademark events.
66 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/16/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/08/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/07/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/06/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/06/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
04/05/2023
GNS1
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
03/08/2023
GNCF
CONTINUATION OF FINAL REFUSAL E-MAILED
03/08/2023
CNCF
SU - ACTION CONTINUING FINAL - WRITTEN
03/08/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/01/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/01/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/01/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/03/2023
GNFR
FINAL REFUSAL E-MAILED
01/03/2023
CNFR
SU - FINAL REFUSAL - WRITTEN
01/03/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/03/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/03/2023
ALIE
ASSIGNED TO LIE
01/03/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/27/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/29/2022
GNRT
NON-FINAL ACTION E-MAILED
06/29/2022
CNRT
SU - NON-FINAL ACTION - WRITTEN
06/29/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/23/2022
IUAF
USE AMENDMENT FILED
06/17/2022
EISU
TEAS STATEMENT OF USE RECEIVED
06/17/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/21/2022
NOAC
CORRECTED NOA E-MAILED
01/21/2022
EX1G
SOU EXTENSION 1 GRANTED
01/20/2022
DPCC
DIVISIONAL PROCESSING COMPLETE
01/20/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/20/2022
EXT1
SOU EXTENSION 1 FILED
01/06/2022
DRRR
DIVISIONAL REQUEST RECEIVED
01/06/2022
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
01/06/2022
EEXT
SOU TEAS EXTENSION RECEIVED
01/06/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/06/2021
CHPB
POST PUBLICATION AMENDMENT - ENTERED
07/02/2021
APET
ASSIGNED TO PETITION STAFF
07/01/2021
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
05/27/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/11/2021
PUBO
PUBLISHED FOR OPPOSITION
05/11/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/21/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/07/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/06/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/06/2021
ALIE
ASSIGNED TO LIE
03/30/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/24/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
03/08/2021
GNFR
FINAL REFUSAL E-MAILED
03/08/2021
CNFR
FINAL REFUSAL WRITTEN
03/08/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/18/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/18/2021
ALIE
ASSIGNED TO LIE
02/18/2021
NREV
NOTICE OF REVIVAL - E-MAILED
11/25/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/25/2020
PETG
PETITION TO REVIVE-GRANTED
11/25/2020
PROA
TEAS PETITION TO REVIVE RECEIVED
11/25/2020
MAB2
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
11/16/2020
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
11/16/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/23/2020
GNRT
NON-FINAL ACTION E-MAILED
04/23/2020
CNRT
NON-FINAL ACTION WRITTEN
04/23/2020
DOCK
ASSIGNED TO EXAMINER
04/16/2020
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
02/04/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/03/2020
NWAP
NEW APPLICATION ENTERED
01/31/2020
Continuous trademark protection
Get notified about every new filing that threatens FAX PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.